Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

May-June 2007; Volume 4,Issue 3
  • You have access
    Editorial
    ANGELIKA M. BURGER and BRIAN LEYLAND-JONES
    Cancer Genomics & Proteomics May 2007, 4 (3) 107;
  • You have access
    An Exploration into Study Design for Biomarker Identification: Issues and Recommendations
    JACQUELINE A. HALL, ROBERT BROWN and JIM PAUL
    Cancer Genomics & Proteomics May 2007, 4 (3) 111-119;
  • You have access
    Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
    DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
    Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;
  • You have access
    Application of Array-based Genomic and Epigenomic Technologies to Unraveling the Heterogeneous Nature of Breast Tumors: On the Road to Individualized Treatment
    MARK ABRAMOVITZ and BRIAN LEYLAND-JONES
    Cancer Genomics & Proteomics May 2007, 4 (3) 135-145;
  • You have access
    Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
    STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
    Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;
  • You have access
    Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
    RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
    Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;
  • You have access
    Cancer Stem Cells and Individualized Therapy
    SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
    Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;
  • You have access
    Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C
    MILÈNE VOLPATO and ROGER M. PHILLIPS
    Cancer Genomics & Proteomics May 2007, 4 (3) 175-186;
  • You have access
    Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
    ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
    Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;
  • You have access
    Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
    HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
    Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;
  • You have access
    Molecular Targets in Metastasis: Lessons from Genomic Approaches
    BARBARA FINGLETON
    Cancer Genomics & Proteomics May 2007, 4 (3) 211-221;
  • You have access
    Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention
    AXEL J. BAUMGARTEN, HEINZ-HERBERT FIEBIG and ANGELIKA M. BURGER
    Cancer Genomics & Proteomics May 2007, 4 (3) 223-231;
  • You have access
    Post-transcriptional Control of the MCT-1-associated Protein DENR/DRP by RNA-binding Protein AUF1
    KRYSTYNA MAZAN-MAMCZARZ and RONALD B. GARTENHAUS
    Cancer Genomics & Proteomics May 2007, 4 (3) 233-239;
  • You have access
    Drug Transporters as Targets for Cancer Chemotherapy
    TAKEO NAKANISHI
    Cancer Genomics & Proteomics May 2007, 4 (3) 241-254;
Back to top
PreviousNext

In this issue

Cancer Genomics & Proteomics
Vol. 4, Issue 3
May-June 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire